Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/22/05 14:30 | 4/20/05 | GCOR | Health | Diagn | In Vitro & In Vivo Diagnostic | Danisco A/s /fi | G7 | T | P.m | 585,908 | 17.40 | 0 | 33,671 | 135 | 58,671 | I | |||||||||||||||
8/29/03 14:34 | 8/28/03 | GCOR | Health | Diagn | In Vitro & In Vivo Diagnostic | Bienaime Jean Jacques | CA | DO | P,CEO | P | 6 | 15.68 | 0 | 0 | 1 | 77 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |